Previous Close | 2.025 |
1-Year Change | -67.7% |
6-Months Change | -40.09% |
3-Months Change | -38.64% |
Moving Avg (50d) | 3.1536 |
Moving Avg (200d) | 3.6014 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 62.8M |
Beta (3-Years) | 2.07 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -89.5% |
EPS (ttm) | -1.71 |
PE Ratio (ttm) | -1.18 |
Dividend Yield | % |
Asset Description: | PDS Biotechnology Corporation |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.985 | 1.924 | 1.883 | 1.823 | 1.721 | 1.62 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.